CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.62, no.2, pp.293-298, 2008 (SCI-Expanded)
Purpose Temozolomide and fotemustine are both active drugs for treating metastatic melanoma. The present study was designed to assess the efficacy and safety of combination therapy with temozolomide + fotemustine in patients with metastatic melanoma.